Literature DB >> 19070611

Overview: Evaluation of metabolism-based drug toxicity in drug development.

Albert P Li.   

Abstract

Drug metabolism can be a key determinant of drug toxicity. A nontoxic parent drug may be biotransformed by drug metabolizing enzymes to toxic metabolites (metabolic activation). Conversely, a toxic drug may be biotransformed to nontoxic metabolites (detoxification). The approaches to evaluate metabolism-based drug toxicity include the identification of toxic metabolites and the evaluation of toxicity in metabolically competent and metabolically compromised systems. A clear understanding of the role of drug metabolism in toxicity can aid the identification of risk factors that may potentiate drug toxicity, and may provide key information for the development of safe drugs.

Entities:  

Mesh:

Year:  2008        PMID: 19070611     DOI: 10.1016/j.cbi.2008.11.013

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  4 in total

1.  Covalent protein binding and tissue distribution of houttuynin in rats after intravenous administration of sodium houttuyfonate.

Authors:  Zhi-peng Deng; Da-fang Zhong; Jian Meng; Xiao-yan Chen
Journal:  Acta Pharmacol Sin       Date:  2012-03-05       Impact factor: 6.150

2.  Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.

Authors:  Carlota Oleaga; Anne Riu; Sandra Rothemund; Andrea Lavado; Christopher W McAleer; Christopher J Long; Keisha Persaud; Narasimhan Sriram Narasimhan; My Tran; Jeffry Roles; Carlos A Carmona-Moran; Trevor Sasserath; Daniel H Elbrecht; Lee Kumanchik; L Richard Bridges; Candace Martin; Mark T Schnepper; Gail Ekman; Max Jackson; Ying I Wang; Reine Note; Jessica Langer; Silvia Teissier; James J Hickman
Journal:  Biomaterials       Date:  2018-08-04       Impact factor: 12.479

Review 3.  Scientific concepts and applications of integrated discrete multiple organ co-culture technology.

Authors:  Loganathan Gayathri; Dharumadurai Dhanasekaran; Mohammad A Akbarsha
Journal:  J Pharmacol Pharmacother       Date:  2015 Apr-Jun

4.  The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline.

Authors:  Margaret L Sutherland; Kristin M Fabre; Danilo A Tagle
Journal:  Stem Cell Res Ther       Date:  2013-12-20       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.